Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 22 April 2014 | By Alexander Gaffney, RAC,
The US Food and Drug Administration (FDA) is taking a page from the Federal Bureau of Investigation (FBI) in the hopes of tracking down some of the most egregious violators of federal food and drug law.
On 15 April 2014, FDA's Office of Criminal Investigations (OCI), FDA's criminal enforcement division, launched a "Most Wanted Fugitives" page complete with 11 profiles of fugitives purported to be behind some of the worst violations of the Federal Food, Drug and Cosmetic Act (FD&C Act) in recent memory.
One alleged fugitive, Dushyant Mehendrabhai Patel, reportedly headed up a North Carolina-based company which sold pre-filled heparin syringes without first conducting sterility testing despite providing assurances that his company had done so. The products were ultimately associated with at least five deaths and hundreds of other injuries requiring hospitalization, FDA said.
Other fugitives contained on the list are reported to have imported counterfeit drugs, marketed mislabeled and unapproved drugs, and diverted and resold pharmaceuticals.
Each profile of a reported fugitive contains a mugshot, a brief case history and the person's name, age and national origin.
FDA Most Wanted Page
Tags: Office of Criminal Investigations, Most Wanted, Fugitive, OCI, Latest News
Regulatory Focus newsletters
All the biggest regulatory news and happenings.